Limited Competition: Specific Pathogen Free Macaque Colonies to Support HIV/AIDS Research (U42 Clinical Trial Not Allowed)
National Institutes of Health
Free. Verify your email, then we send one reminder only.
- Posted
- Dec 17, 2025
- Closes
- Sep 25, 2026 (in 57 days)
Similar opportunities open now
- Limited Competition: National Primate Research Centers (P51) (Clinical Trials Not Allowed)OpenNational Institutes of HealthCloses in 57 days
- Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)OpenNational Institutes of HealthCloses Nov 2027
- Animal and Biological Material Resource Centers (P40 Clinical Trial Not Allowed)OpenNational Institutes of HealthCloses Sep 2028
- Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)OpenNational Institutes of HealthCloses Nov 2027
- High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)OpenNational Institutes of HealthCloses Mar 2027Up to $1.5M
Classification and identifiers
- Solicitation number
- PAR-24-129
- Assistance listing (CFDA)
- 93.351
Amount
Amount not published by the funder
Who can apply
Public colleges and universities can apply here. Check the eligibility details below to see if your organization fits.
Other Eligible Applicants include the following:Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. see NOFO for eligibility details…
About this opportunity
The purpose of this Notice of Funding Opportunity (NOFO) is to provide continuing support for specific pathogen-free (SPF) macaque colonies previously funded under the auspices of PAR-21-089 and PAR-18-669 that support Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS) research. Breeding colonies are essential to sustain appropriate SPF macaques for research related to HIV/AIDS. Pedigree SPF macaques are free of certain viruses, which may confound the results of HIV/AIDS-related investigations or present a risk to the personnel who care for the animals. The SPF macaques are genetically characterized for major histocompatibility complex (MHC) class I types, because MHC class I genotypes have large effects on macaque immune responses to Simian Immunodeficiency Virus...
Related opportunities
- Limited Competition: National Primate Research Centers (P51) (Clinical Trials Not Allowed)National Institutes of HealthCloses in 57 days
- Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)National Institutes of HealthCloses Nov 2027
- Animal and Biological Material Resource Centers (P40 Clinical Trial Not Allowed)National Institutes of HealthCloses Sep 2028
- Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)National Institutes of HealthCloses Nov 2027
- High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)National Institutes of HealthCloses Mar 2027Up to $1.5M
- Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)National Institutes of HealthCloses Jan 2028Up to $200K